GBT Guerbet SA

7.228USD6.590 EUR · EPA-0.15%Mkt Cap: 90.71M USDP/E: —

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…

Institutional holders10 on file

Key Statistics

Company
Market Cap90.71M USD
Enterprise Value469.83M USD
Revenue (TTM)867.18M USD
Gross Profit621.00M USD
Net Income (TTM)-118.82M USD
Revenue/Share69.12 USD
Last Price7.228 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.7K
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0000032526
Valuation
P/E (Trailing)—
P/E (Forward)8.30
PEG0.07
EV/EBITDA29.91
EV/Revenue0.54
P/S0.10
P/B0.34
EPS (TTM)-12.57 USD
EPS (Forward)0.87 USD
52W Range
6.3616% of range20.03
52W High20.03 USD
52W Low6.361 USD
Profitability
Gross Margin70.89%
Oper. Margin-3.19%
EBITDA Margin1.81%
Profit Margin-13.56%
ROE-40.57%
ROA-11.65%
ROIC1.45%
ROCE1.17%
Growth
Revenue Growth-2.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF88.94M USD
CapEx (TTM)40.15M USD
FCF Margin5.82%
FCF Yield55.66%
Net Debt390.30M USD
Net Debt/EBITDA24.84
Net Debt/FCF7.73
Balance Sheet
Debt/Equity1.65
Current Ratio0.96
Quick Ratio0.43
Book Value/Sh21.38 USD
Cash/Share11.56 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield2.34%
Payout Ratio0.00%
Ex-Div DateJul 1, 2024
Pay Date—
Splits
Last Split4:1
Split DateJan 23, 2014
Analyst Consensus
Rating—
Target (Mean)8.391 USD
Upside (mean)+16.1%
Target Range7.678 USD – 9.103 USD
7.678+16.1% to mean9.103
# Analysts2
Ownership
Shares Out.12.57M
Float5.05M
Insiders63.21%
Institutions3.90%
Technical
SMA 507.286 (-0.8%)
SMA 2009.842 (-26.6%)
Beta1.09
S&P 52W Chg12.00%
Avg Vol (30d)10.84K
Avg Vol (10d)10.80K
Technical Indicators
RSI (14)52.2
MACD0.0222
MACD Signal-0.0201
MACD Hist.+0.0423
BB Upper7.662 USD
BB Middle7.063 USD
BB Lower6.463 USD
BB Width16.97%
ATR (14)0.1891 USD
Vol Ratio (20d)1.00x

About Guerbet (EPA: GBT)

›

Guerbet (EPA: GBT) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 2,653 employees.

The shares were at 6.590 EUR on 19 November 2026, down 62.0% over 52 weeks. Its 52-week range is 5.800 EUR to 18.26 EUR: the price is 63.9% below the high and 13.6% above the low.

Its market capitalisation is 82.70M EUR.

Guerbet reports return on equity of -40.6%, an operating margin of -3.2% and revenue down 2.0% year over year.

Its debt exceeds its cash by 355.85M EUR, a debt-to-equity ratio of 1.65. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 7.650 EUR is 16.1% above the current price.